33^rd World Congress on Neurology and Neuroscience November 21-22, 2022 Dubai, UAE

Kaja is an experienced neurobiologist with a long-standing research track record in academia and the biotech and pharmaceutical industry. Kaja currently serves as Associate Director of Preclinical Research at the Vision Research Center at the University of Missouri - Kansas City, School of Medicine. He is the Director of Microscopy of the imaging core facility at the Vision Research Center and also holds an appointment to Assistant Professor of Ophthalmology. His NIH-funded research program focuses on human neurological and neurodegenerative diseases, visual disorders and inflammation. Kaja obtained his B.Sc. (Hons.) degree in Molecular Biology and Biochemistry from Durham University, UK and holds a Ph.D. degree in Medicine/Neuroscience from Leiden University, The Netherlands. Prior to joining the faculty at the University of Missouri - Kansas City, he has performed postdoctoral work at The University of British Columbia (Vancouver, B.C., Canada) and the University of North Texas Health Science Center (Fort Worth, TX). In addition to his academic work, Dr. Kaja has worked and consulted for a number of pharmaceutical companies, incl. Novo Nordisk A/S, Bayer AG, Neuromed Pharmaceuticals Inc., and NeuroSearch A/S. He is CEO and co-founder of K&P Scientific LLC, a scientific consulting company headquartered in Kansas City, MO.

Pathophysiological mechanisms underlying neurodegenerative, neurological and visual disorders.

Giovanni Antioco Putzu is working as professor in Neurology and Clinical Neurophysiology in Casa di Cura Sant’Elena, Italy. He has published more than 15 papers in reputed journals and has been serving as an editorial board member of repute

Neuroimaging and Interventional Radiology

Sybille Krauß studied biotechnology at the Technische Fachhochschule Berlin until 2002. As graduate student she worked at the Max Planck Institute for Molecular Genetics and received her PhD in 2005 for her thesis „Characterization of microtubule-associated PP2A and their target proteins”. After this, she conducted research as postdoc at the Charité in the group of Prof. Susann Schweiger. Since 2010 Sybille Krauß is groupleader at DZNE in Bonn

Neurodegenerative Diseases

Kuldip Sidhu, PhD, BSC (Medical) is a stem cell expert at the Faculty of Medicine, University of New South Wales, Australia. His post doc training is from St Louis MO USA (1979-80) in assisted reproductive technology and he also worked with Prof James Thompson, Wisconsin USA (2000) who produced the first human embryonic stem cells in 1998. His research focus is on neural stem cells derived from both the embryonic and non-embryonic sources for developing future cell therapies for various neurodegenerative diseases, like Alzheimer’s, Parkinson’s and other neuronal diseases. He has established a state-of-the-art facility to study the cell and developmental biology of stem cells. The Stem Cell Lab (SCL) has expertise to culture, propagate, differentiate, engineer and transplant in animal models the neural stem cells. In addition, he has expertise in the derivation of new human embryonic stem cell lines including their clonal propagation. His lab was first to produce two hESC lines, Endeavour (E) 1 & 2 from Australia and E2 is listed on NIH registry USA for distribution. SCL has embarked on iPS Technology and produced over 100 iPSC clones from Alzheimer’s patients for studying the disease processes and drug discovery using genetic engineering and microarray technology.

Neurodegenerative Diseases, Endocrinology